Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 2988 | 2011 |
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1343 | 2013 |
Randomized trial of oral teriflunomide for relapsing multiple sclerosis P O'Connor, JS Wolinsky, C Confavreux, G Comi, L Kappos, TP Olsson, ... New England Journal of Medicine 365 (14), 1293-1303, 2011 | 1269 | 2011 |
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis T Olsson, LF Barcellos, L Alfredsson Nature Reviews Neurology 13 (1), 25-36, 2017 | 1222 | 2017 |
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions B Kornek, MK Storch, R Weissert, E Wallstroem, A Stefferl, T Olsson, ... The American journal of pathology 157 (1), 267-276, 2000 | 1195 | 2000 |
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 968 | 2018 |
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ... Multiple Sclerosis Journal 24 (2), 96-120, 2018 | 930 | 2018 |
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 907 | 2019 |
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ... Nature genetics 53 (6), 817-829, 2021 | 809 | 2021 |
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice JC Souberbielle, JJ Body, JM Lappe, M Plebani, Y Shoenfeld, TJ Wang, ... Autoimmunity reviews 9 (11), 709-715, 2010 | 780 | 2010 |
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial C Confavreux, P O'Connor, G Comi, MS Freedman, AE Miller, TP Olsson, ... The Lancet Neurology 13 (3), 247-256, 2014 | 684 | 2014 |
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology MK Storch, A Stefferl, U Brehm, R Weissert, E Wallström, ... Brain Pathology 8 (4), 681-694, 1998 | 641 | 1998 |
Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis F Lundmark, K Duvefelt, E Iacobaeus, I Kockum, E Wallström, M Khademi, ... Nature genetics 39 (9), 1108-1113, 2007 | 623 | 2007 |
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 565 | 2019 |
Neurofascin as a novel target for autoantibody-mediated axonal injury EK Mathey, T Derfuss, MK Storch, KR Williams, K Hales, DR Woolley, ... The Journal of experimental medicine 204 (10), 2363-2372, 2007 | 494 | 2007 |
Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. T Olsson, WW Zhi, B Höjeberg, V Kostulas, YP Jiang, G Anderson, ... The Journal of clinical investigation 86 (3), 981-985, 1990 | 459 | 1990 |
Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies G Luna, P Alping, J Burman, K Fink, A Fogdell-Hahn, M Gunnarsson, ... JAMA neurology 77 (2), 184-191, 2020 | 442 | 2020 |
Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis I Jelcic, F Al Nimer, J Wang, V Lentsch, R Planas, I Jelcic, A Madjovski, ... Cell 175 (1), 85-100. e23, 2018 | 433 | 2018 |
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women AK Hedström, T Olsson, L Alfredsson Multiple Sclerosis Journal 18 (9), 1334-1336, 2012 | 433 | 2012 |
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis AK Hedstrom, M Baarnhielm, T Olsson, L Alfredsson Neurology 73 (9), 696-701, 2009 | 419 | 2009 |